Oxidative stress reduces the longevity of the ovary by direct cell loss and chronic inflammation
But as of today, Glucagon-Like peptide 1 receptor agonists (GLP1-RAs), sodium-glucose cotransporter 2 inhibitors (SGLT2is), dipeptidyl peptidase 4 inhibitors (DPP4is) and mineralocorticoid receptor antagonists, are quickly becoming part of, if not the drugs of choice for diabetes, especially in cases with heart, kidney or liver comorbidities [9,10,11,12]
Perhaps the most philosophically unsettling side effect is what happens beyond appetite
All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding anticipated consumer savings, convenience and accessibility
JAMA Diabetes & Endocrinology
These findings were challenged by a more recent in vitro study, using fecal microbiota from healthy donors (Peng et al., 2024)